Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM5 | Q9NZQ8 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 6/20 | 0.32 |
| ▸ | RORC | P51449 | 1/20 | 0.32 |
| ▸ | FADS1 | O60427 | 1/20 | 0.32 |
| ▸ | PNMT | P11086 | 3/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346114 | 0.93 | KIF11 (0.36) | EGLN1KIF11PNMTCYP19A1CETP | |
| SCHEMBL31346109 | 0.87 | ELANE (0.34) | EGLN1KIF11MAOBELANECYP3A4 | |
| SCHEMBL31346005 | 0.87 | ELANE (0.34) | EGLN1KIF11MAOBELANECYP3A4 | |
| SCHEMBL31346117 | 0.84 | CYP19A1 (0.45) | KIF11FFAR1CYP19A1CETPELANE | |
| SCHEMBL31345995 | 0.84 | CYP19A1 (0.45) | KIF11FFAR1CYP19A1CETPELANE | |
| SCHEMBL31345991 | 0.84 | ABCG2 (0.37) | FFAR1MAOBCYP19A1CYP3A4 | |
| SCHEMBL31346029 | 0.82 | CYP11B1 (0.40) | EGLN1KIF11CYP3A4 | |
| SCHEMBL31346022 | 0.81 | FFAR1 (0.39) | FFAR1MAOBPNMT | |
| SCHEMBL31346086 | 0.81 | MRGPRX4 (0.34) | EGLN1KIF11ELANEMRGPRX4 | |
| SCHEMBL31345984 | 0.76 | PNMT (0.35) | MAOBPNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |